| Annual Financials | 2025 | 2026 | TTM |
Revenue  | 98 | 148 | 0 |
| Expenses | 82 | 134 | 0 |
| EBITDA | 15 | 14 | 0 |
| Operating Profit % | 16 % | 9 % | 0 % |
| Depreciation | 5 | 5 | 0 |
| Interest | 4 | 3 | 0 |
| Profit Before Tax | 7 | 6 | 0 |
| Tax | 2 | 1 | 0 |
| Net Profit | 5 | 5 | 0 |
| EPS in ₹ | 6.94 | 4.49 | 0.00 |
Astonea Labs
Astonea Labs
345.00
-3.15
(-0.90%)
Market Cap
362.59 Cr
PE Ratio
80.97
Volume
1,000.00
Day High - Low
345.00 - 345.00
52W High-Low
369.00 - 118.00
Key Fundamentals
Market Cap
362.59 Cr
EPS
4.49
PE Ratio
80.97
PB Ratio
6.41
Book Value
54.35
EBITDA
13.90
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
7.90
Debt to Equity
1.28
Actual
Company News
View All News
Astonea Labs clarifies FY25 filing gaps
Sep 19, 2026
Sep 19, 2026Astonea Labs Limited addresses BSE queries regarding missing PDF and declaration files for its FY25 standalone results. The company submitted the requisite documents to ensure regulatory compliance.
Astonea Labs promoter buys 14,000 sharesSep 17, 2026
Sep 17, 2026Ashish Gulati, promoter of Astonea Labs Limited, acquired 14,000 equity shares via open market on September 15-16, 2026. His holding rose to 70.94% from 70.81%.
Astonea Labs Ltd has appointed Mr. Chander Shekhar of M/s. Chander Shekhar & Associates as its internal auditor for the financial year 2026-27, following a recommendation by the Audit Committee.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,801.00 | #1 4,32,120.23 | 36.04 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 36.68 | |
9,249.00 | 2,45,531.89 | 84.24 | 11,067.00 | 13.95 | 2,568 | 65.50 | 51.70 | |
4,767.30 | 1,81,332.77 | 84.71 | 13,886.20 | 20.34 | 2,138 | 3.28 | 41.12 | |
1,145.70 | 1,14,284.01 | 25.27 | 27,657.90 | 17.64 | 5,026 | -34.90 | 47.64 | |
1,344.00 | 1,08,576.18 | 32.50 | 29,044.60 | 2.24 | 3,870 | -39.18 | 34.78 | |
1,984.00 | 1,07,197.94 | 98.20 | 6,867.80 | 22.01 | 890 | #1 123.93 | 58.70 | |
2,535.00 | 1,04,706.93 | 50.04 | 14,636.40 | 14.85 | 1,938 | 29.13 | 61.75 | |
1,206.20 | 1,00,679.14 | 32.41 | 35,058.60 | 3.90 | 4,158 | -69.10 | 53.84 | |
1,676.80 | 96,479.37 | 25.84 | 34,145.20 | 5.56 | 3,503 | 25.21 | 50.30 | |
2,031.20 | 92,884.74 | #1 16.82 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 31.59 |
Growth Rate
Revenue Growth
51.59 %
Net Income Growth
-16.67 %
Cash Flow Change
-247.57 %
ROE
-72.81 %
ROCE
-59.43 %
EBITDA Margin (Avg.)
-40.20 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2025 | 2026 |
| Total Assets | 103 | 146 |
| Fixed Assets | 26 | 31 |
| Current Assets | 71 | 98 |
| Capital Work in Progress | 4 | 8 |
| Investments | 0 | 0 |
| Other Assets | 73 | 107 |
| Total Equity & Liabilities | 103 | 146 |
| Current Liabilities | 65 | 68 |
| Non Current Liabilities | 20 | 21 |
| Total Equity | 18 | 57 |
| Reserve & Surplus | 11 | 47 |
| Share Capital | 8 | 11 |
Cash Flow
| Cash Flow | 2025 | 2026 |
| Net Cash Flow | -0 | 0 |
| Investing Activities | -11 | -20 |
| Operating Activities | 9 | -14 |
| Financing Activities | 2 | 34 |
Share Holding
| % Holding | Aug 2024 | May 2025 | Jun 2025 | Sept 2025 | Mar 2026 |
| Promoter | 98.43 % | 72.30 % | 72.30 % | 72.30 % | 72.30 % |
| FIIs | 0.00 % | 0.00 % | 8.01 % | 2.51 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 4.55 % | 0.35 % | 0.07 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 12.24 % | 11.51 % | 17.06 % | 22.25 % |
| Others | 1.57 % | 15.45 % | 3.62 % | 7.77 % | 5.38 % |
| No of Share Holders | 36 | 36 | 1,014 | 437 | 376 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 11 Jul 2025 |  Quarterly Result Announcement | NA | 11 Jul 2025 | 146.10 | 151.85 |
| 10 Nov 2025 | Quarterly Result Announcement | NA | 10 Nov 2025 | 156.00 | 159.90 |
| 27 Dec 2025 |  Annual General Meeting | NA | 27 Dec 2025 | 150.00 | 160.05 |
| 27 Mar 2026 |  Extraordinary General Meeting | NA | 27 Mar 2026 | 155.00 | 157.00 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 227.00 | 230.55 |
| 24 Jul 2026 | Quarterly Result Announcement | NA | 24 Jul 2026 | 278.00 | 261.75 |
| 21 Aug 2026 | Annual General Meeting | NA | 21 Aug 2026 | 261.75 | 279.00 |
Announcements
Closure of Trading Window6 days ago
6 days agoResubmission Of Financial Results For The Half Year Ended 31.03.2025 In Response To BSE Communication9 days ago
9 days agoResubmission Of Financial Results For The Financial Year Ended 31.03.2025 In Response To BSE CommunicationSep 19, 2026
Sep 19, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 18, 2026
Sep 18, 2026Submission Of Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulation 2015.Sep 17, 2026
Sep 17, 2026Disclosures Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011.Sep 17, 2026
Sep 17, 2026Appointment Of Internal AuditorSep 09, 2026
Sep 09, 2026Board Meeting Outcome for Meeting Held On 9Th September 2026.Sep 09, 2026
Sep 09, 2026Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationAug 21, 2026
Aug 21, 2026Re-Appointment Of Ms. Pooja Singh As Director Of The CompanyAug 21, 2026
Aug 21, 2026Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 21, 2026
Aug 21, 2026Shareholder Meeting / Postal Ballot-Outcome of AGMAug 21, 2026
Aug 21, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 25, 2026
Jul 25, 2026Reg. 34 (1) Annual Report.Jul 24, 2026
Jul 24, 2026Notice Of 9Th Annual General Meeting ("AGM") Of The Company For The Financial Year 2025-26Jul 24, 2026
Jul 24, 2026Revision In Re-Appointment Of Tax AuditorJul 24, 2026
Jul 24, 2026Audited Consolidated Financial Results For The Half Year And Year Ended 31.03.2026Jul 24, 2026
Jul 24, 2026Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 24Th July 2026Jul 24, 2026
Jul 24, 2026Board Meeting Intimation for Approval Of Audited Consolidated Financial Results For The Financial Year Ended 31.03.2026 And Others.Jul 18, 2026
Jul 18, 2026Intimation Under Regulation 30-Execution And Registration Of Sale Deed For Sale Of Immovable Properties.Jul 17, 2026
Jul 17, 2026Successful Completion Of Regulatory Inspection Of Manufacturing Facility By Supreme Board Of Drugs And Medical Appliances (SBDMA) Ministry Of Health And Population Republic Of Yemen.Jul 14, 2026
Jul 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 13, 2026
Jul 13, 2026Submission Of Additional Documents With Reference To Earlier Corporate Announcement Dated 30Th May 2026 And BSEs Communication Regarding Signing Of Financial ResultsJun 20, 2026
Jun 20, 2026Submission Of Half-Yearly Disclosure On Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As AmendedMay 30, 2026
May 30, 2026Statement Of Deviation & Variation For The Half Year Ended 31.03.2026May 30, 2026
May 30, 2026Re-Appointment Of Tax AuditorMay 30, 2026
May 30, 2026Re-Appointment Of Cost AuditorMay 30, 2026
May 30, 2026Re-Appointment Of Secretarial AuditorMay 30, 2026
May 30, 2026Audited Standalone Financial Results For The Half Year And Year Ended 31.03.2026May 30, 2026
May 30, 2026Board Meeting Outcome for Meeting Held On 30Th May 2026May 30, 2026
May 30, 2026Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For The Half Year And Year Ended On 31St March 2026May 25, 2026
May 25, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2026
Apr 29, 2026Intimation Under Regulation 30 Of SEBI LODR (Regulations) 2015- Fire Incident At Manufacturing FacilityApr 27, 2026
Apr 27, 2026Statement On Redressal Of Investor Grievances/Complaints For The Quarter Ended 31.03.2026Apr 23, 2026
Apr 23, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Apr 09, 2026Announcement under Regulation 30 (LODR)-AcquisitionMar 31, 2026
Mar 31, 2026Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationMar 27, 2026
Mar 27, 2026Approval Of Variation In The Objects Of The Initial Public Offer (IPO)Mar 27, 2026
Mar 27, 2026Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 27, 2026
Mar 27, 2026Shareholder Meeting / Postal Ballot-Outcome of EGMMar 27, 2026
Mar 27, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 03, 2026
Mar 03, 2026Notice Of Extra-Ordinary General Meeting Of Astonea Labs LimitedMar 02, 2026
Mar 02, 2026Board Meeting Outcome for For Meeting Held On 27Th February 2026Feb 27, 2026
Feb 27, 2026Board Meeting Intimation for Consideration And Approval For Variation In The Objects Of The Initial Public Offer (IPO) And Others.Feb 24, 2026
Feb 24, 2026Acquisition Of Immovable Property (Land)Feb 13, 2026
Feb 13, 2026Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 06Th February 2026Feb 06, 2026
Feb 06, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 26, 2026
Jan 26, 2026Statement On Redressal Of Investor Grievances/ Complaints For The Quarter Ended 31.12.2025Jan 19, 2026
Jan 19, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Jan 07, 2026Technical Indicators
RSI(14)
Neutral 68.48
ATR(14)
Less Volatile 10.45
STOCH(9,6)
Neutral 60.28
STOCH RSI(14)
Neutral 61.73
MACD(12,26)
Bullish 2.75
ADX(14)
Strong Trend 26.40
UO(9)
Bearish 64.84
ROC(12)
Uptrend And Accelerating 19.38
WillR(14)
Neutral -25.53
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
